PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-82

  1. 4,103 Posts.
    lightbulb Created with Sketch. 1866
    Great News Today

    Although it would appear that Anthony Fippis ,s trip to San fran was to no avail as far as investment @ market was concerned ( Failure to create interest @ Market from his recent trip )

    Lets hope that behind the scenes he was able to put across to the investment world out there, that he spoke to that, should our Combo trial be succesful, could we look towards an initial onboarding of a fund to the tune of around $6 - $7 mil to take us into a 6 - 9 patient 6 month trial to see the effects of the combo therapy

    This would be an initial investment wherby if the small number combo trial is a success then look towards that huge investment from them and backing us into the US market that i have gone on about forever


    If i do not see something released within these next 6 - 8 weeks then personally and this is my own personal opinion i will take his overseas trip as being a complete failure, and like he did back in 2011 when he tried to advance 1101 for cancer

    As in


    Afandin has advised ANP that it has made significant progress in attracting interest in the further development of ATL1101 and is currently in discussions with a number of corporate and investor groups, some of which are currently undertaking due diligence on ATL1101.

    THEN SOME 6 MONTHS later after 1 year the agreement was terminated because funds could not be raised

    We were informed the market was tough out there

    So As was mentioned unlike the above where his efforts had to be reported to market, because he is now a member of ANP as mentioned earlier his discussions and findings will be kept within the inner sanctum we wont know how he went in San Fran

    So for me 6 -8 weeks should be long enough to see a major Ann of intent to move this into human trials with investment backing

    If he was succesful in San Fran Todays Ann should trigger both sides to get these negotiations underway and plans for clinical trial in motion

    That is my run down like i said, the pipe line thus far

    Has never let me down.

    Its now down to Anthony to deliver on these results,

    For once the path forwards has been taken of Marks shoulders

    Is he the right man for the Job, well you have my time line

    SEE HOW HE GOES
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.